These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6996809)
1. The research logic of radiation oncology in combined modality therapy. Rubin P; Salazar OM Cancer Treat Rep; 1980; 64(2-3):473-80. PubMed ID: 6996809 [TBL] [Abstract][Full Text] [Related]
2. Anticancer Drug Development: The Way Forward. Connors T Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985 [TBL] [Abstract][Full Text] [Related]
7. The Challenge of Developing New Therapies for Childhood Cancers. Balis FM Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032 [TBL] [Abstract][Full Text] [Related]
8. New and emerging radiosensitizers and radioprotectors. Spalding AC; Lawrence TS Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698 [TBL] [Abstract][Full Text] [Related]
9. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer. Belani CP Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783 [TBL] [Abstract][Full Text] [Related]
10. Adjuvant breast cancer therapy: current status and future strategies--growth kinetics and the improved drug therapy of breast cancer. Norton L Semin Oncol; 1999 Feb; 26(1 Suppl 3):1-4. PubMed ID: 10203263 [TBL] [Abstract][Full Text] [Related]
11. The Goal of Cancer Treatment. Balis FM Oncologist; 1998; 3(4):V. PubMed ID: 10388118 [TBL] [Abstract][Full Text] [Related]
12. Overview of bladder cancer trials in the Radiation Therapy Oncology Group. Shipley WU; Kaufman DS; Tester WJ; Pilepich MV; Sandler HM; Cancer; 2003 Apr; 97(8 Suppl):2115-9. PubMed ID: 12673704 [TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
14. Curative and palliative aspects of regional chemotherapy in combination with surgery. Müller H; Hilger R Support Care Cancer; 2003 Jan; 11(1):1-10. PubMed ID: 12527948 [TBL] [Abstract][Full Text] [Related]
15. Optimal management of locally advanced cervical carcinoma. Keys H; Gibbons SK J Natl Cancer Inst Monogr; 1996; (21):89-92. PubMed ID: 9023835 [TBL] [Abstract][Full Text] [Related]
16. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1. Lunsford LD; Flickinger JC; Larson D Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030 [TBL] [Abstract][Full Text] [Related]
18. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
19. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue. Hagemeister FB Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984 [TBL] [Abstract][Full Text] [Related]
20. Radiation oncology research in the cancer and leukemia group B. Bogart JA; Seagren SL; Glicksman A Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3628s-34s. PubMed ID: 16740797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]